Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
- DOI
- 10.1016/j.jconrel.2019.04.018
- Published
- 2019 Jun 10
- Container
- Journal of controlled release : official journal of the Controlled Release Society
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2019.04.018,
title = {Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.},
author = {Zhang J and Nie S and Zu Y and Abbasi M and Cao J and Li C and Wu D and Labib S and Brackee G and Shen CL and Wang S},
year = {2019},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
doi = {10.1016/j.jconrel.2019.04.018},
url = {https://doi.org/10.1016/j.jconrel.2019.04.018}
}RIS
TY - JOUR TI - Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles. AU - Zhang J AU - Nie S AU - Zu Y AU - Abbasi M AU - Cao J AU - Li C AU - Wu D AU - Labib S AU - Brackee G AU - Shen CL AU - Wang S PY - 2019 JO - Journal of controlled release : official journal of the Controlled Release Society DO - 10.1016/j.jconrel.2019.04.018 UR - https://doi.org/10.1016/j.jconrel.2019.04.018 ER -
APA
J, Z., S, N., Y, Z., M, A., J, C., C, L., D, W., S, L., G, B., CL, S., & S, W. (2019). Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2019.04.018
Source records
- pubmed · retrieved 2026-09-26T08:40:03.247Z